Abstracts and posters
Sharing your work at SfE BES is a fantastic opportunity to get useful feedback and ideas to progress your work as well as boosting your presentation and networking skills.
Accepted abstracts are presented at the event either as a poster, e-poster or as an oral presentation. They will also be published online in Endocrine Abstracts. Abstracts are accepted on the understanding that the work has not been published or presented elsewhere, excluding associated Society for Endocrinology events.
Submit your Abstract
PostersDuring this year’s meeting there will also be a selection of clinical cases presented in an electronic poster (ePoster) format. These clinical cases ePosters cover a range of topics within the field of endocrinology and will be available on the ePoster stations found throughout the exhibition hall.
ePostersDuring this year’s meeting there will be a selection of clinical cases presented in an electronic poster (ePoster) format. These clinical cases ePosters cover a range of topics within the field of endocrinology and will be available on the ePoster stations found throughout the exhibition hall.
We hope that this new format will ensure that the exposure to these clinical cases is extended past the end of the SfE BES 2016 meeting. ePosters will be available to view throughout the meeting, and after the meeting on the Endocrine Abstracts portal.
Authors who have been selected for Featured Clinical Cases will also be asked to upload an ePoster in addition to their physical poster, to further increase the exposure to the authors work.
Please note: if you have been selected for an ePoster then you are NOT required to bring a physical poster to the SfE BES 2016 meeting. Only the Featured Clinical Cases will be asked to upload an ePoster in addition to their physical poster.
You will be invited and encouraged to upload your poster presentation (in PDF format) for viewing during Society for Endocrinology BES 2017 and after the meeting. Details of uploading your ePoster will be sent in the coming months.
We hope that this will enhance delegates’ educational experience and increase exposure of the work you present.
DEADLINE FOR RECEIPT OF ABSTRACTS: 19 June 2017
Any abstracts received after this date will not be considered.
Please read the information below before submitting your abstract.
Accepted abstracts will be published in Endocrine Abstracts online and are accepted on the understanding that the work has not been published or presented elsewhere, excluding other Society for Endocrinology events.
Submit your abstract
- The abstract should be no longer than 300 words (including numbers and symbols). You must select one category for your abstract from the following list, and indicate this category clearly on your submission:
- Please note that you will be required to register to the abstract submission system and then verify your email address before being able to submit your abstract.
Submit your Abstract
The Society of Endocrinology hopes to attract a wide range of Endocrinology related research to its meeting to be shared and viewed by members of the field. Below you will find the abstract category list for SfE BES 2017:
- Bone and calcium
- Clinical biochemistry
- Clinical trials - Recruitment and awareness
- Neoplasia, cancer and late effects
- Nursing practice
- Diabetes and cardiovascular
- Obesity and metabolism
- Neuroendocrinology and pituitary
- Adrenal and steroids
New for the Society for Endocrinology BES conference in 2017, we are introducing an additional category for abstract submission.
Clinical trials – Recruitment and awareness
This abstract category has been introduced to publicise clinical trials including NIHR-funded, investigator- led and commercial studies. The aim is to increase the awareness of healthcare professionals to currently recruiting studies, or studies that are to start in the near future in order to facilitate recruitment.
Abstracts will be reviewed for suitability by members of the Programme Committee but will not be scored. It is not expected that submitted abstracts will contain any results and accepted abstracts will be offered a poster display in a distinct area from the main scientific poster exhibition. If you wish to submit trial results, please do so in a different category, appropriate to the disease investigated.
Please include details of the clinical trial registration ID (ISRCTN or ClinicalTrials.gov).
Prizes and awards
Accepted abstracts may be considered for a range of prizes and awards (over 20 available), which are presented during the conference and recognised at the Society for Endocrinology BES 2017 Awards Ceremony.
In 2017 there will be a wide range of prizes for clinical and basic science presentations. If you would like to be considered for any of these, please indicate your interest on the online abstract submission form.
Please note that case reports will only be accepted if they illustrate something significantly new or especially unusual in the clinical case load of the submitting endocrine unit.
If your case is accepted for presentation you will be entitled to a discounted publication in Endocrinology, Diabetes & Metabolism Case Reports, a Society for Endocrinology-endorsed online resource.
Accepted abstracts will be published in Endocrine Abstracts, both in print and on the web, and are accepted on the understanding that the work has not been published or presented elsewhere in substantially the same form. Authors must not submit the same research (or substantially similar material) concurrently to any other journal or primary publication, or do so until the outcome of their submission to Endocrine Abstracts is known. Submission of an abstract assumes approval for publication in advance of the meeting in both the web and print versions of Endocrine Abstracts. Copyright of accepted abstracts will automatically be assigned to Bioscientifica Ltd – submission indicates your agreement to this.
Conditions of acceptance
Abstracts are also accepted on the understanding that they will be presented at the meeting either as a poster or as an oral presentation. Any author failing to present an accepted abstract at this meeting will automatically be excluded from submitting any future abstracts.
The Programme Committee reserves the right of the final decision regarding acceptance of abstracts and the form of presentation. Notification of acceptance or rejection will be sent to authors in August 2017. Detailed instructions concerning oral presentations and poster sessions will be emailed to qualifying authors with notification of acceptance.
Please note, abstracts that are accepted as poster presentations will need to be displayed on 2x1 metre PORTRAIT poster boards.